Figure 4.
PR-2 had higher expression of CD302+ on CD14+ and CD34+ cell populations. CD302+ protein expression was assessed by flow cytometry. The box plots show the proportion of CD302+ in PR (PR-1 and PR-2) and GR groups for (A) stem and progenitor cells (CD34+), (B) monocytes (CD14+), (C) granulocytes (CD33+CD11b+CD15+), (D) Mo-MDSCs (HLA-DR−LIN−CD33+CD11b+CD66b−CD14+), (E) pDCs (CD123+CD303+), and (F) mDCs (HLA-DR+LIN−CD14−CD123−/low).

PR-2 had higher expression of CD302+ on CD14+ and CD34+ cell populations. CD302+ protein expression was assessed by flow cytometry. The box plots show the proportion of CD302+ in PR (PR-1 and PR-2) and GR groups for (A) stem and progenitor cells (CD34+), (B) monocytes (CD14+), (C) granulocytes (CD33+CD11b+CD15+), (D) Mo-MDSCs (HLA-DR−LIN−CD33+CD11b+CD66b−CD14+), (E) pDCs (CD123+CD303+), and (F) mDCs (HLA-DR+LIN−CD14−CD123−/low).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal